Global Deep Brain Stimulation

Deep Brain Stimulation Comprehensive Study by Type (Subthalamic DBS, Globus Pallidus DBS, Thalamic DBS, Pedunculopontine Nucleus DBS), Application (Pain Management, Epilepsy, Essential Tremor, Obsessive-Compulsive Disorder (OCD), Depression, Dystonia, Parkinson’s disease, Others), Product (Single Channel Deep Brain Stimulator, Dual Channel Deep Brain Stimulator) Players and Region - Global Market Outlook to 2028

Deep Brain Stimulation Market by XX Submarkets | Forecast Years 2023-2028  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
About Deep Brain Stimulation
Deep brain stimulation is a process that involves implanting electrodes within certain areas of the brain. These electrodes produce electrical impulses that regulate abnormal pulses. And these electrical impulses also affect certain cells and chemicals within the brain. This treatment is done for people with movement disorders including essential tremor, Parkinson’s disease, and dystonia, and psychiatric conditions. This treatment is reserved for people who aren’t able to control symptoms with medicines. According to Emory University in Atlanta, Ga. there are 3.4 million Americans who have epilepsy, over one-third are drug resistant. The expansion of DBS has made new options to access and examine malfunctioning brain circuits and to test the therapeutic potential of regulating the output of these circuits in a broad range of disorders.

AttributesDetails
Study Period2018-2028
Base Year2022
UnitValue (USD Million)


In this players are continuously investing in technology advance devices and also focus on organic and inorganic growth strategies. The global Deep Brain Stimulation market is not much competitive. In terms of market share, few of the key players including Medtronic, Aleva presently dominate the global market. Key vendors with a prominent share in the global market are concentrating on escalating their client base the world. Analyst at AMA Research estimates that United States Players will contribute the maximum growth to Global Deep Brain Stimulation market throughout the forecasted period. Established and emerging Players should take a closer view at their existing organizations and reinvent traditional business and operating models to adapt to the future.

Boston Scientific Corp. (United States), Medtronic plc (Ireland), St. Jude Medical Inc. (United States), Aleva Neurotherapeutics (Switzerland), Beijing Pins Medical (China), NeuroPace (United States), NeuroSigma (United States) and Abbott Laboratories (United States) are some of the key players that are part of study coverage.

Segmentation Overview
AMA Research has segmented the market of Global Deep Brain Stimulation market by Type (Subthalamic DBS, Globus Pallidus DBS, Thalamic DBS and Pedunculopontine Nucleus DBS), Application (Pain Management, Epilepsy, Essential Tremor, Obsessive-Compulsive Disorder (OCD), Depression, Dystonia, Parkinson’s disease and Others) and Region.



On the basis of geography, the market of Deep Brain Stimulation has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by Product, the sub-segment i.e. Single Channel Deep Brain Stimulator will boost the Deep Brain Stimulation market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Influencing Trend:
Technological Innovations

Market Growth Drivers:
Needs of an Ageing Population Worldwide and Increasing Depression and Alzheimer Disease

Challenges:
Highly Focal Point Is Insufficient As a Means of Addressing Dysfunction of Multiple Circuits

Restraints:
Progress/Risk of Technology and Substitutes Threat

Opportunities:
DBS Science Helps To Define the Future Role of This Technology in the Growth of Novel Therapeutics for the Most Challenging Disorders Affecting the Human Brain

Market Leaders and their expansionary development strategies
In November 2023, STG a developer of DBS systems, acquires Neuroelectrics, a developer of noninvasive neuromodulation technologies, to integrate non-invasive neuromodulation therapies into its DBS platform and offer patients a broader range of treatment options.
In November 2023, Boston Scientific received CE Mark approval for its Vercise DBS system for the treatment of Tourette's syndrome. This approval marks the first time that DBS has been approved for the treatment of Tourette's syndrome in Europe.
FDA approved DMS as a treatment for essential tremor in 1997, and for Parkinson’s disease in 2002. Before this procedure, a neurosurgeon uses either MRI or CT scanning to detect the exact target area within the brain where the electric signals will generate the Parkinson’s disease symptoms.

Key Target Audience
Venture Capitalists and Private Equity Firms, New Entrants/Investors, Analysts and Strategic Business Planners, Deep Brain Stimulation device Manufacturers, Suppliers, and Distributors, Government Regulatory and Research Organizations and End-Use Industries

About Approach
To evaluate and validate the market size various sources including primary and secondary analysis is utilized. AMA Research follows regulatory standards such as NAICS/SIC/ICB/TRCB, to have a better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with the purpose to understand the companies positioning regarding the market value, volume, and their market share for regional as well as global.

Further to bring relevance specific to any niche market we set and apply a number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders, etc., and work towards appointment generation.

The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, the analyst team keeps preparing a set of questionnaires, and after getting the appointee list; the target audience is then tapped and segregated with various mediums and channels that are feasible for making connections that including email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey, etc.

Report Objectives / Segmentation Covered

By Type
  • Subthalamic DBS
  • Globus Pallidus DBS
  • Thalamic DBS
  • Pedunculopontine Nucleus DBS
By Application
  • Pain Management
  • Epilepsy
  • Essential Tremor
  • Obsessive-Compulsive Disorder (OCD)
  • Depression
  • Dystonia
  • Parkinson’s disease
  • Others
By Product
  • Single Channel Deep Brain Stimulator
  • Dual Channel Deep Brain Stimulator

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Needs of an Ageing Population Worldwide
      • 3.2.2. Increasing Depression and Alzheimer Disease
    • 3.3. Market Challenges
      • 3.3.1. Highly Focal Point Is Insufficient As a Means of Addressing Dysfunction of Multiple Circuits
    • 3.4. Market Trends
      • 3.4.1. Technological Innovations
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Deep Brain Stimulation, by Type, Application, Product and Region (value and price ) (2017-2022)
    • 5.1. Introduction
    • 5.2. Global Deep Brain Stimulation (Value)
      • 5.2.1. Global Deep Brain Stimulation by: Type (Value)
        • 5.2.1.1. Subthalamic DBS
        • 5.2.1.2. Globus Pallidus DBS
        • 5.2.1.3. Thalamic DBS
        • 5.2.1.4. Pedunculopontine Nucleus DBS
      • 5.2.2. Global Deep Brain Stimulation by: Application (Value)
        • 5.2.2.1. Pain Management
        • 5.2.2.2. Epilepsy
        • 5.2.2.3. Essential Tremor
        • 5.2.2.4. Obsessive-Compulsive Disorder (OCD)
        • 5.2.2.5. Depression
        • 5.2.2.6. Dystonia
        • 5.2.2.7. Parkinson’s disease
        • 5.2.2.8. Others
      • 5.2.3. Global Deep Brain Stimulation by: Product (Value)
        • 5.2.3.1. Single Channel Deep Brain Stimulator
        • 5.2.3.2. Dual Channel Deep Brain Stimulator
      • 5.2.4. Global Deep Brain Stimulation Region
        • 5.2.4.1. South America
          • 5.2.4.1.1. Brazil
          • 5.2.4.1.2. Argentina
          • 5.2.4.1.3. Rest of South America
        • 5.2.4.2. Asia Pacific
          • 5.2.4.2.1. China
          • 5.2.4.2.2. Japan
          • 5.2.4.2.3. India
          • 5.2.4.2.4. South Korea
          • 5.2.4.2.5. Taiwan
          • 5.2.4.2.6. Australia
          • 5.2.4.2.7. Rest of Asia-Pacific
        • 5.2.4.3. Europe
          • 5.2.4.3.1. Germany
          • 5.2.4.3.2. France
          • 5.2.4.3.3. Italy
          • 5.2.4.3.4. United Kingdom
          • 5.2.4.3.5. Netherlands
          • 5.2.4.3.6. Rest of Europe
        • 5.2.4.4. MEA
          • 5.2.4.4.1. Middle East
          • 5.2.4.4.2. Africa
        • 5.2.4.5. North America
          • 5.2.4.5.1. United States
          • 5.2.4.5.2. Canada
          • 5.2.4.5.3. Mexico
    • 5.3. Global Deep Brain Stimulation (Price)
      • 5.3.1. Global Deep Brain Stimulation by: Type (Price)
  • 6. Deep Brain Stimulation: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2022)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Boston Scientific Corp. (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Medtronic plc (Ireland)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. St. Jude Medical Inc. (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Aleva Neurotherapeutics (Switzerland)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Beijing Pins Medical (China)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. NeuroPace (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. NeuroSigma (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Abbott Laboratories (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
  • 7. Global Deep Brain Stimulation Sale, by Type, Application, Product and Region (value and price ) (2023-2028)
    • 7.1. Introduction
    • 7.2. Global Deep Brain Stimulation (Value)
      • 7.2.1. Global Deep Brain Stimulation by: Type (Value)
        • 7.2.1.1. Subthalamic DBS
        • 7.2.1.2. Globus Pallidus DBS
        • 7.2.1.3. Thalamic DBS
        • 7.2.1.4. Pedunculopontine Nucleus DBS
      • 7.2.2. Global Deep Brain Stimulation by: Application (Value)
        • 7.2.2.1. Pain Management
        • 7.2.2.2. Epilepsy
        • 7.2.2.3. Essential Tremor
        • 7.2.2.4. Obsessive-Compulsive Disorder (OCD)
        • 7.2.2.5. Depression
        • 7.2.2.6. Dystonia
        • 7.2.2.7. Parkinson’s disease
        • 7.2.2.8. Others
      • 7.2.3. Global Deep Brain Stimulation by: Product (Value)
        • 7.2.3.1. Single Channel Deep Brain Stimulator
        • 7.2.3.2. Dual Channel Deep Brain Stimulator
      • 7.2.4. Global Deep Brain Stimulation Region
        • 7.2.4.1. South America
          • 7.2.4.1.1. Brazil
          • 7.2.4.1.2. Argentina
          • 7.2.4.1.3. Rest of South America
        • 7.2.4.2. Asia Pacific
          • 7.2.4.2.1. China
          • 7.2.4.2.2. Japan
          • 7.2.4.2.3. India
          • 7.2.4.2.4. South Korea
          • 7.2.4.2.5. Taiwan
          • 7.2.4.2.6. Australia
          • 7.2.4.2.7. Rest of Asia-Pacific
        • 7.2.4.3. Europe
          • 7.2.4.3.1. Germany
          • 7.2.4.3.2. France
          • 7.2.4.3.3. Italy
          • 7.2.4.3.4. United Kingdom
          • 7.2.4.3.5. Netherlands
          • 7.2.4.3.6. Rest of Europe
        • 7.2.4.4. MEA
          • 7.2.4.4.1. Middle East
          • 7.2.4.4.2. Africa
        • 7.2.4.5. North America
          • 7.2.4.5.1. United States
          • 7.2.4.5.2. Canada
          • 7.2.4.5.3. Mexico
    • 7.3. Global Deep Brain Stimulation (Price)
      • 7.3.1. Global Deep Brain Stimulation by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Deep Brain Stimulation: by Type(USD Million)
  • Table 2. Deep Brain Stimulation Subthalamic DBS , by Region USD Million (2017-2022)
  • Table 3. Deep Brain Stimulation Globus Pallidus DBS , by Region USD Million (2017-2022)
  • Table 4. Deep Brain Stimulation Thalamic DBS , by Region USD Million (2017-2022)
  • Table 5. Deep Brain Stimulation Pedunculopontine Nucleus DBS , by Region USD Million (2017-2022)
  • Table 6. Deep Brain Stimulation: by Application(USD Million)
  • Table 7. Deep Brain Stimulation Pain Management , by Region USD Million (2017-2022)
  • Table 8. Deep Brain Stimulation Epilepsy , by Region USD Million (2017-2022)
  • Table 9. Deep Brain Stimulation Essential Tremor , by Region USD Million (2017-2022)
  • Table 10. Deep Brain Stimulation Obsessive-Compulsive Disorder (OCD) , by Region USD Million (2017-2022)
  • Table 11. Deep Brain Stimulation Depression , by Region USD Million (2017-2022)
  • Table 12. Deep Brain Stimulation Dystonia , by Region USD Million (2017-2022)
  • Table 13. Deep Brain Stimulation Parkinson’s disease , by Region USD Million (2017-2022)
  • Table 14. Deep Brain Stimulation Others , by Region USD Million (2017-2022)
  • Table 15. Deep Brain Stimulation: by Product(USD Million)
  • Table 16. Deep Brain Stimulation Single Channel Deep Brain Stimulator , by Region USD Million (2017-2022)
  • Table 17. Deep Brain Stimulation Dual Channel Deep Brain Stimulator , by Region USD Million (2017-2022)
  • Table 18. South America Deep Brain Stimulation, by Country USD Million (2017-2022)
  • Table 19. South America Deep Brain Stimulation, by Type USD Million (2017-2022)
  • Table 20. South America Deep Brain Stimulation, by Application USD Million (2017-2022)
  • Table 21. South America Deep Brain Stimulation, by Product USD Million (2017-2022)
  • Table 22. Brazil Deep Brain Stimulation, by Type USD Million (2017-2022)
  • Table 23. Brazil Deep Brain Stimulation, by Application USD Million (2017-2022)
  • Table 24. Brazil Deep Brain Stimulation, by Product USD Million (2017-2022)
  • Table 25. Argentina Deep Brain Stimulation, by Type USD Million (2017-2022)
  • Table 26. Argentina Deep Brain Stimulation, by Application USD Million (2017-2022)
  • Table 27. Argentina Deep Brain Stimulation, by Product USD Million (2017-2022)
  • Table 28. Rest of South America Deep Brain Stimulation, by Type USD Million (2017-2022)
  • Table 29. Rest of South America Deep Brain Stimulation, by Application USD Million (2017-2022)
  • Table 30. Rest of South America Deep Brain Stimulation, by Product USD Million (2017-2022)
  • Table 31. Asia Pacific Deep Brain Stimulation, by Country USD Million (2017-2022)
  • Table 32. Asia Pacific Deep Brain Stimulation, by Type USD Million (2017-2022)
  • Table 33. Asia Pacific Deep Brain Stimulation, by Application USD Million (2017-2022)
  • Table 34. Asia Pacific Deep Brain Stimulation, by Product USD Million (2017-2022)
  • Table 35. China Deep Brain Stimulation, by Type USD Million (2017-2022)
  • Table 36. China Deep Brain Stimulation, by Application USD Million (2017-2022)
  • Table 37. China Deep Brain Stimulation, by Product USD Million (2017-2022)
  • Table 38. Japan Deep Brain Stimulation, by Type USD Million (2017-2022)
  • Table 39. Japan Deep Brain Stimulation, by Application USD Million (2017-2022)
  • Table 40. Japan Deep Brain Stimulation, by Product USD Million (2017-2022)
  • Table 41. India Deep Brain Stimulation, by Type USD Million (2017-2022)
  • Table 42. India Deep Brain Stimulation, by Application USD Million (2017-2022)
  • Table 43. India Deep Brain Stimulation, by Product USD Million (2017-2022)
  • Table 44. South Korea Deep Brain Stimulation, by Type USD Million (2017-2022)
  • Table 45. South Korea Deep Brain Stimulation, by Application USD Million (2017-2022)
  • Table 46. South Korea Deep Brain Stimulation, by Product USD Million (2017-2022)
  • Table 47. Taiwan Deep Brain Stimulation, by Type USD Million (2017-2022)
  • Table 48. Taiwan Deep Brain Stimulation, by Application USD Million (2017-2022)
  • Table 49. Taiwan Deep Brain Stimulation, by Product USD Million (2017-2022)
  • Table 50. Australia Deep Brain Stimulation, by Type USD Million (2017-2022)
  • Table 51. Australia Deep Brain Stimulation, by Application USD Million (2017-2022)
  • Table 52. Australia Deep Brain Stimulation, by Product USD Million (2017-2022)
  • Table 53. Rest of Asia-Pacific Deep Brain Stimulation, by Type USD Million (2017-2022)
  • Table 54. Rest of Asia-Pacific Deep Brain Stimulation, by Application USD Million (2017-2022)
  • Table 55. Rest of Asia-Pacific Deep Brain Stimulation, by Product USD Million (2017-2022)
  • Table 56. Europe Deep Brain Stimulation, by Country USD Million (2017-2022)
  • Table 57. Europe Deep Brain Stimulation, by Type USD Million (2017-2022)
  • Table 58. Europe Deep Brain Stimulation, by Application USD Million (2017-2022)
  • Table 59. Europe Deep Brain Stimulation, by Product USD Million (2017-2022)
  • Table 60. Germany Deep Brain Stimulation, by Type USD Million (2017-2022)
  • Table 61. Germany Deep Brain Stimulation, by Application USD Million (2017-2022)
  • Table 62. Germany Deep Brain Stimulation, by Product USD Million (2017-2022)
  • Table 63. France Deep Brain Stimulation, by Type USD Million (2017-2022)
  • Table 64. France Deep Brain Stimulation, by Application USD Million (2017-2022)
  • Table 65. France Deep Brain Stimulation, by Product USD Million (2017-2022)
  • Table 66. Italy Deep Brain Stimulation, by Type USD Million (2017-2022)
  • Table 67. Italy Deep Brain Stimulation, by Application USD Million (2017-2022)
  • Table 68. Italy Deep Brain Stimulation, by Product USD Million (2017-2022)
  • Table 69. United Kingdom Deep Brain Stimulation, by Type USD Million (2017-2022)
  • Table 70. United Kingdom Deep Brain Stimulation, by Application USD Million (2017-2022)
  • Table 71. United Kingdom Deep Brain Stimulation, by Product USD Million (2017-2022)
  • Table 72. Netherlands Deep Brain Stimulation, by Type USD Million (2017-2022)
  • Table 73. Netherlands Deep Brain Stimulation, by Application USD Million (2017-2022)
  • Table 74. Netherlands Deep Brain Stimulation, by Product USD Million (2017-2022)
  • Table 75. Rest of Europe Deep Brain Stimulation, by Type USD Million (2017-2022)
  • Table 76. Rest of Europe Deep Brain Stimulation, by Application USD Million (2017-2022)
  • Table 77. Rest of Europe Deep Brain Stimulation, by Product USD Million (2017-2022)
  • Table 78. MEA Deep Brain Stimulation, by Country USD Million (2017-2022)
  • Table 79. MEA Deep Brain Stimulation, by Type USD Million (2017-2022)
  • Table 80. MEA Deep Brain Stimulation, by Application USD Million (2017-2022)
  • Table 81. MEA Deep Brain Stimulation, by Product USD Million (2017-2022)
  • Table 82. Middle East Deep Brain Stimulation, by Type USD Million (2017-2022)
  • Table 83. Middle East Deep Brain Stimulation, by Application USD Million (2017-2022)
  • Table 84. Middle East Deep Brain Stimulation, by Product USD Million (2017-2022)
  • Table 85. Africa Deep Brain Stimulation, by Type USD Million (2017-2022)
  • Table 86. Africa Deep Brain Stimulation, by Application USD Million (2017-2022)
  • Table 87. Africa Deep Brain Stimulation, by Product USD Million (2017-2022)
  • Table 88. North America Deep Brain Stimulation, by Country USD Million (2017-2022)
  • Table 89. North America Deep Brain Stimulation, by Type USD Million (2017-2022)
  • Table 90. North America Deep Brain Stimulation, by Application USD Million (2017-2022)
  • Table 91. North America Deep Brain Stimulation, by Product USD Million (2017-2022)
  • Table 92. United States Deep Brain Stimulation, by Type USD Million (2017-2022)
  • Table 93. United States Deep Brain Stimulation, by Application USD Million (2017-2022)
  • Table 94. United States Deep Brain Stimulation, by Product USD Million (2017-2022)
  • Table 95. Canada Deep Brain Stimulation, by Type USD Million (2017-2022)
  • Table 96. Canada Deep Brain Stimulation, by Application USD Million (2017-2022)
  • Table 97. Canada Deep Brain Stimulation, by Product USD Million (2017-2022)
  • Table 98. Mexico Deep Brain Stimulation, by Type USD Million (2017-2022)
  • Table 99. Mexico Deep Brain Stimulation, by Application USD Million (2017-2022)
  • Table 100. Mexico Deep Brain Stimulation, by Product USD Million (2017-2022)
  • Table 101. Deep Brain Stimulation: by Type(USD/Units)
  • Table 102. Company Basic Information, Sales Area and Its Competitors
  • Table 103. Company Basic Information, Sales Area and Its Competitors
  • Table 104. Company Basic Information, Sales Area and Its Competitors
  • Table 105. Company Basic Information, Sales Area and Its Competitors
  • Table 106. Company Basic Information, Sales Area and Its Competitors
  • Table 107. Company Basic Information, Sales Area and Its Competitors
  • Table 108. Company Basic Information, Sales Area and Its Competitors
  • Table 109. Company Basic Information, Sales Area and Its Competitors
  • Table 110. Deep Brain Stimulation: by Type(USD Million)
  • Table 111. Deep Brain Stimulation Subthalamic DBS , by Region USD Million (2023-2028)
  • Table 112. Deep Brain Stimulation Globus Pallidus DBS , by Region USD Million (2023-2028)
  • Table 113. Deep Brain Stimulation Thalamic DBS , by Region USD Million (2023-2028)
  • Table 114. Deep Brain Stimulation Pedunculopontine Nucleus DBS , by Region USD Million (2023-2028)
  • Table 115. Deep Brain Stimulation: by Application(USD Million)
  • Table 116. Deep Brain Stimulation Pain Management , by Region USD Million (2023-2028)
  • Table 117. Deep Brain Stimulation Epilepsy , by Region USD Million (2023-2028)
  • Table 118. Deep Brain Stimulation Essential Tremor , by Region USD Million (2023-2028)
  • Table 119. Deep Brain Stimulation Obsessive-Compulsive Disorder (OCD) , by Region USD Million (2023-2028)
  • Table 120. Deep Brain Stimulation Depression , by Region USD Million (2023-2028)
  • Table 121. Deep Brain Stimulation Dystonia , by Region USD Million (2023-2028)
  • Table 122. Deep Brain Stimulation Parkinson’s disease , by Region USD Million (2023-2028)
  • Table 123. Deep Brain Stimulation Others , by Region USD Million (2023-2028)
  • Table 124. Deep Brain Stimulation: by Product(USD Million)
  • Table 125. Deep Brain Stimulation Single Channel Deep Brain Stimulator , by Region USD Million (2023-2028)
  • Table 126. Deep Brain Stimulation Dual Channel Deep Brain Stimulator , by Region USD Million (2023-2028)
  • Table 127. South America Deep Brain Stimulation, by Country USD Million (2023-2028)
  • Table 128. South America Deep Brain Stimulation, by Type USD Million (2023-2028)
  • Table 129. South America Deep Brain Stimulation, by Application USD Million (2023-2028)
  • Table 130. South America Deep Brain Stimulation, by Product USD Million (2023-2028)
  • Table 131. Brazil Deep Brain Stimulation, by Type USD Million (2023-2028)
  • Table 132. Brazil Deep Brain Stimulation, by Application USD Million (2023-2028)
  • Table 133. Brazil Deep Brain Stimulation, by Product USD Million (2023-2028)
  • Table 134. Argentina Deep Brain Stimulation, by Type USD Million (2023-2028)
  • Table 135. Argentina Deep Brain Stimulation, by Application USD Million (2023-2028)
  • Table 136. Argentina Deep Brain Stimulation, by Product USD Million (2023-2028)
  • Table 137. Rest of South America Deep Brain Stimulation, by Type USD Million (2023-2028)
  • Table 138. Rest of South America Deep Brain Stimulation, by Application USD Million (2023-2028)
  • Table 139. Rest of South America Deep Brain Stimulation, by Product USD Million (2023-2028)
  • Table 140. Asia Pacific Deep Brain Stimulation, by Country USD Million (2023-2028)
  • Table 141. Asia Pacific Deep Brain Stimulation, by Type USD Million (2023-2028)
  • Table 142. Asia Pacific Deep Brain Stimulation, by Application USD Million (2023-2028)
  • Table 143. Asia Pacific Deep Brain Stimulation, by Product USD Million (2023-2028)
  • Table 144. China Deep Brain Stimulation, by Type USD Million (2023-2028)
  • Table 145. China Deep Brain Stimulation, by Application USD Million (2023-2028)
  • Table 146. China Deep Brain Stimulation, by Product USD Million (2023-2028)
  • Table 147. Japan Deep Brain Stimulation, by Type USD Million (2023-2028)
  • Table 148. Japan Deep Brain Stimulation, by Application USD Million (2023-2028)
  • Table 149. Japan Deep Brain Stimulation, by Product USD Million (2023-2028)
  • Table 150. India Deep Brain Stimulation, by Type USD Million (2023-2028)
  • Table 151. India Deep Brain Stimulation, by Application USD Million (2023-2028)
  • Table 152. India Deep Brain Stimulation, by Product USD Million (2023-2028)
  • Table 153. South Korea Deep Brain Stimulation, by Type USD Million (2023-2028)
  • Table 154. South Korea Deep Brain Stimulation, by Application USD Million (2023-2028)
  • Table 155. South Korea Deep Brain Stimulation, by Product USD Million (2023-2028)
  • Table 156. Taiwan Deep Brain Stimulation, by Type USD Million (2023-2028)
  • Table 157. Taiwan Deep Brain Stimulation, by Application USD Million (2023-2028)
  • Table 158. Taiwan Deep Brain Stimulation, by Product USD Million (2023-2028)
  • Table 159. Australia Deep Brain Stimulation, by Type USD Million (2023-2028)
  • Table 160. Australia Deep Brain Stimulation, by Application USD Million (2023-2028)
  • Table 161. Australia Deep Brain Stimulation, by Product USD Million (2023-2028)
  • Table 162. Rest of Asia-Pacific Deep Brain Stimulation, by Type USD Million (2023-2028)
  • Table 163. Rest of Asia-Pacific Deep Brain Stimulation, by Application USD Million (2023-2028)
  • Table 164. Rest of Asia-Pacific Deep Brain Stimulation, by Product USD Million (2023-2028)
  • Table 165. Europe Deep Brain Stimulation, by Country USD Million (2023-2028)
  • Table 166. Europe Deep Brain Stimulation, by Type USD Million (2023-2028)
  • Table 167. Europe Deep Brain Stimulation, by Application USD Million (2023-2028)
  • Table 168. Europe Deep Brain Stimulation, by Product USD Million (2023-2028)
  • Table 169. Germany Deep Brain Stimulation, by Type USD Million (2023-2028)
  • Table 170. Germany Deep Brain Stimulation, by Application USD Million (2023-2028)
  • Table 171. Germany Deep Brain Stimulation, by Product USD Million (2023-2028)
  • Table 172. France Deep Brain Stimulation, by Type USD Million (2023-2028)
  • Table 173. France Deep Brain Stimulation, by Application USD Million (2023-2028)
  • Table 174. France Deep Brain Stimulation, by Product USD Million (2023-2028)
  • Table 175. Italy Deep Brain Stimulation, by Type USD Million (2023-2028)
  • Table 176. Italy Deep Brain Stimulation, by Application USD Million (2023-2028)
  • Table 177. Italy Deep Brain Stimulation, by Product USD Million (2023-2028)
  • Table 178. United Kingdom Deep Brain Stimulation, by Type USD Million (2023-2028)
  • Table 179. United Kingdom Deep Brain Stimulation, by Application USD Million (2023-2028)
  • Table 180. United Kingdom Deep Brain Stimulation, by Product USD Million (2023-2028)
  • Table 181. Netherlands Deep Brain Stimulation, by Type USD Million (2023-2028)
  • Table 182. Netherlands Deep Brain Stimulation, by Application USD Million (2023-2028)
  • Table 183. Netherlands Deep Brain Stimulation, by Product USD Million (2023-2028)
  • Table 184. Rest of Europe Deep Brain Stimulation, by Type USD Million (2023-2028)
  • Table 185. Rest of Europe Deep Brain Stimulation, by Application USD Million (2023-2028)
  • Table 186. Rest of Europe Deep Brain Stimulation, by Product USD Million (2023-2028)
  • Table 187. MEA Deep Brain Stimulation, by Country USD Million (2023-2028)
  • Table 188. MEA Deep Brain Stimulation, by Type USD Million (2023-2028)
  • Table 189. MEA Deep Brain Stimulation, by Application USD Million (2023-2028)
  • Table 190. MEA Deep Brain Stimulation, by Product USD Million (2023-2028)
  • Table 191. Middle East Deep Brain Stimulation, by Type USD Million (2023-2028)
  • Table 192. Middle East Deep Brain Stimulation, by Application USD Million (2023-2028)
  • Table 193. Middle East Deep Brain Stimulation, by Product USD Million (2023-2028)
  • Table 194. Africa Deep Brain Stimulation, by Type USD Million (2023-2028)
  • Table 195. Africa Deep Brain Stimulation, by Application USD Million (2023-2028)
  • Table 196. Africa Deep Brain Stimulation, by Product USD Million (2023-2028)
  • Table 197. North America Deep Brain Stimulation, by Country USD Million (2023-2028)
  • Table 198. North America Deep Brain Stimulation, by Type USD Million (2023-2028)
  • Table 199. North America Deep Brain Stimulation, by Application USD Million (2023-2028)
  • Table 200. North America Deep Brain Stimulation, by Product USD Million (2023-2028)
  • Table 201. United States Deep Brain Stimulation, by Type USD Million (2023-2028)
  • Table 202. United States Deep Brain Stimulation, by Application USD Million (2023-2028)
  • Table 203. United States Deep Brain Stimulation, by Product USD Million (2023-2028)
  • Table 204. Canada Deep Brain Stimulation, by Type USD Million (2023-2028)
  • Table 205. Canada Deep Brain Stimulation, by Application USD Million (2023-2028)
  • Table 206. Canada Deep Brain Stimulation, by Product USD Million (2023-2028)
  • Table 207. Mexico Deep Brain Stimulation, by Type USD Million (2023-2028)
  • Table 208. Mexico Deep Brain Stimulation, by Application USD Million (2023-2028)
  • Table 209. Mexico Deep Brain Stimulation, by Product USD Million (2023-2028)
  • Table 210. Deep Brain Stimulation: by Type(USD/Units)
  • Table 211. Research Programs/Design for This Report
  • Table 212. Key Data Information from Secondary Sources
  • Table 213. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Deep Brain Stimulation: by Type USD Million (2017-2022)
  • Figure 5. Global Deep Brain Stimulation: by Application USD Million (2017-2022)
  • Figure 6. Global Deep Brain Stimulation: by Product USD Million (2017-2022)
  • Figure 7. South America Deep Brain Stimulation Share (%), by Country
  • Figure 8. Asia Pacific Deep Brain Stimulation Share (%), by Country
  • Figure 9. Europe Deep Brain Stimulation Share (%), by Country
  • Figure 10. MEA Deep Brain Stimulation Share (%), by Country
  • Figure 11. North America Deep Brain Stimulation Share (%), by Country
  • Figure 12. Global Deep Brain Stimulation: by Type USD/Units (2017-2022)
  • Figure 13. Global Deep Brain Stimulation share by Players 2022 (%)
  • Figure 14. Global Deep Brain Stimulation share by Players (Top 3) 2022(%)
  • Figure 15. Global Deep Brain Stimulation share by Players (Top 5) 2022(%)
  • Figure 16. BCG Matrix for key Companies
  • Figure 17. Boston Scientific Corp. (United States) Revenue, Net Income and Gross profit
  • Figure 18. Boston Scientific Corp. (United States) Revenue: by Geography 2022
  • Figure 19. Medtronic plc (Ireland) Revenue, Net Income and Gross profit
  • Figure 20. Medtronic plc (Ireland) Revenue: by Geography 2022
  • Figure 21. St. Jude Medical Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 22. St. Jude Medical Inc. (United States) Revenue: by Geography 2022
  • Figure 23. Aleva Neurotherapeutics (Switzerland) Revenue, Net Income and Gross profit
  • Figure 24. Aleva Neurotherapeutics (Switzerland) Revenue: by Geography 2022
  • Figure 25. Beijing Pins Medical (China) Revenue, Net Income and Gross profit
  • Figure 26. Beijing Pins Medical (China) Revenue: by Geography 2022
  • Figure 27. NeuroPace (United States) Revenue, Net Income and Gross profit
  • Figure 28. NeuroPace (United States) Revenue: by Geography 2022
  • Figure 29. NeuroSigma (United States) Revenue, Net Income and Gross profit
  • Figure 30. NeuroSigma (United States) Revenue: by Geography 2022
  • Figure 31. Abbott Laboratories (United States) Revenue, Net Income and Gross profit
  • Figure 32. Abbott Laboratories (United States) Revenue: by Geography 2022
  • Figure 33. Global Deep Brain Stimulation: by Type USD Million (2023-2028)
  • Figure 34. Global Deep Brain Stimulation: by Application USD Million (2023-2028)
  • Figure 35. Global Deep Brain Stimulation: by Product USD Million (2023-2028)
  • Figure 36. South America Deep Brain Stimulation Share (%), by Country
  • Figure 37. Asia Pacific Deep Brain Stimulation Share (%), by Country
  • Figure 38. Europe Deep Brain Stimulation Share (%), by Country
  • Figure 39. MEA Deep Brain Stimulation Share (%), by Country
  • Figure 40. North America Deep Brain Stimulation Share (%), by Country
  • Figure 41. Global Deep Brain Stimulation: by Type USD/Units (2023-2028)
List of companies from research coverage that are profiled in the study
  • Boston Scientific Corp. (United States)
  • Medtronic plc (Ireland)
  • St. Jude Medical Inc. (United States)
  • Aleva Neurotherapeutics (Switzerland)
  • Beijing Pins Medical (China)
  • NeuroPace (United States)
  • NeuroSigma (United States)
  • Abbott Laboratories (United States)
Select User Access Type

Key Highlights of Report


Nov 2023 151 Pages 87 Tables Base Year: 2022 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Deep Brain Stimulation Quantitative research analysis
Global Deep Brain Stimulation Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The standard version of the report profiles players such as Boston Scientific Corp. (United States), Medtronic plc (Ireland), St. Jude Medical Inc. (United States), Aleva Neurotherapeutics (Switzerland), Beijing Pins Medical (China), NeuroPace (United States), NeuroSigma (United States) and Abbott Laboratories (United States) etc.
The Study can be customized subject to feasibility and data availability. Please connect with our sales representative for further information.
"Technological Innovations" is seen as one of major influencing trends for Deep Brain Stimulation Market during projected period 2022-2028.
The Deep Brain Stimulation market study includes a random mix of players, including both market leaders and some top growing emerging players. Connect with our sales executive to get a complete company list in our research coverage.

Know More About Global Deep Brain Stimulation Report?

Have a Query? Click Here

Other Related Reports

Wound Care Management Products Comprehensive Study by Type (Acute Wounds, Chronic Wounds), Application (Surgical wounds, Ulcers, Burn, Trauma wounds, Others), Distribution Channel (Supermarket/Hyperm...
$ 3450
Dental Lab Comprehensive Study by Type (Restorative, Implant, Oral Care), Material (Metal Ceramic, Ceramic (Zirconia, Glass Ceramic)), Equipment Type (Lasers, Systems & Part, Hygiene Maintenance Devi...
$ 3450
Artificial Ventilation Comprehensive Study by Type (Constant Pressure Type, Constant Volume Type), Application (Operation Room, Intensive Care Units, Emergency Room, Dental, Home Care), Ventilators (...
$ 3750
Automated Sample Storage Systems Comprehensive Study by Type (System Unit, Reagents & Consumables), End Users (Hospitals, Diagnostic Labs, Chemical Industries, Biopharmaceutical Industries, Research ...
$ 3750
Medical Equipment Maintenance Comprehensive Study by Type (Preventive, Operation), Application (Hospitals & Clinics, Diagnostic Centers, Others), Service Providers (OEM (Multi-Vendors), ISO, In-House...
$ 3650
Blood Transfusion Comprehensive Study by Type (Y-type, Straight, Others), Blood Bank Function Type (Collection, Processing, Testing, Storage, Transportation), Product (Blood Bag and Accessory, Blood ...
$ 3650